Mechanistic investigation of immunosuppression in patients with condyloma acuminata

Molecular Medicine Reports

Volumn 8, Issue 2, 2013, Pages 480-486

  Shi, Yu Jie ^a   Yang, Jian ^a   Yang, Wenlin ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Condyloma acuminatum; Human papillomavirus; MyD88; Toll like receptor

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; MYELOID DIFFERENTIATION FACTOR 88; PROGRAMMED DEATH 1 RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1;

ADAPTIVE IMMUNITY; ADULT; ARTICLE; B LYMPHOCYTE; CASE REPORT; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELLULAR IMMUNITY; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE; HELPER CELL; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; INNATE IMMUNITY; MALE; NATURAL KILLER CELL; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; WESTERN BLOTTING;

ADULT; CONDYLOMATA ACUMINATA; CYTOKINES; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION; HUMANS; IMMUNE TOLERANCE; MALE; MIDDLE AGED; MYELOID DIFFERENTIATION FACTOR 88; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH2 CELLS; TOLL-LIKE RECEPTORS; YOUNG ADULT;

HUMAN PAPILLOMAVIRUS;

EID: 84879986034     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1511     Document Type: Article

References (28)

1. O'Mahony C: Genital warts: current and future management options. Am J Clin Dermatol 6: 239-243, 2005.
2. McMurray HR, Nguyen D, Westbrook TF and McAnce DJ: Biology of human papillomaviruses. Int J Exp Pathol 82: 15-33, 2001.
3. Partridge JM and Koutsky LA: Genital human papillomavirus infection in men. Lancet Infect Dis 6: 21-31, 2006.
4. Akira S and Takeda K: Toll-like receptor signalling. Nat Rev Immunol 4: 499-511, 2004.
5. Xagorari A and Chlichlia K: Toll-like receptors and viruses: induction of innate antiviral immune responses. Open Microbiol J 2: 49-59, 2008.
6. Sin JI: MyD88 signal is required for more efficient induction of Ag-specific adaptive immune responses and antitumor resistance in a human papillomavirus E7 DNA vaccine model. Vaccine 29: 4125-4131, 2011.
7. Ahmed AM, Madkan V and Tyring SK: Human papillomaviruses and genital disease. Dermatol Clin 24: 157-165, 2006.
8. Narayan S, Choyce A, Linedale R, et al: Epithelial expression of human papillomavirus type 16 E7 protein results in peripheral CD8 T-cell suppression mediated by CD4+CD25+ T cells. Eur J Immunol 39: 481-490, 2009.
9. Liu XS, Leerberg J, MacDonald K, Leggatt GR and Frazer IH: IFN-gamma promotes generation of IL-10 secreting CD4+T cells that suppress generation of CD8 responses in an antigen-experienced host. J Immunol 183: 51-58, 2009.
10. Cao Y, Zhao J, Lei Z, et al: Local accumulation of FOXP3+regulatory T cells: evidence for an immune evasion mechanism in patients with large condylomata acuminata. J Immunol 180: 7681-7686, 2008.
11. Del Mistro A, Koss LG, Braunstein J, Bennett B, Saccomano G and Simons KM: Condylomata acuminata of the urinary bladder. Natural history, viral typing and DNA content. Am J Surg Pathol 12: 205-215, 1988.
12. Daud II, Scott ME, Ma Y, Shiboski S, Farhat S and Moscicki AB: Association between toll-like receptor expression and human papillomavirus type 16 persistence. Int J Cancer 128: 879-886, 2011.
13. Shi YJ, Xiong F, Yang J, et al: The expression and significance of MyD88 in condyloma acuminatum. Zhong Guo PiFu Xing Bing Xue Za Zhi 24: 626-628, 2010 (In Chinese).
14. Xu Y, Zhu KJ, Zhu N, Jiang DH, Chen XZ and Cheng H: Expression of Foxp3+CD4+CD25+ regulatory T cells and Th1/Th2, Tc1/Tc2 profiles in the peripheral blood of patients with condyloma acuminatum. Clin Exp Dermatol 34: 229-235, 2009.
15. Villa LL, Costa RL, Petta CA, et al: High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up. Br J Cancer 95: 1459-1466, 2006.
16. Ku JK, Kwon HJ, Kim MY, et al: Expression of Toll-like receptors in verruca and molluscum contagiosum. J Korean Med Sci 23: 307-314, 2008.
17. Yang R, Murillo FM, Cui H, et al: Papillomavirus-like particles stimulate murine bone marrow-derived dendritic cells to produce alpha interferon and Th1 immune responses via MyD88. J Virol 78: 11152-11160, 2004.
18. Ochs HD, Gambineri E and Torgerson TR: IPEX, FOXP3 and regulatory T-cells: a model for autoimmunity. Immunol Res 38: 112-121, 2007.
19. van Maren WW, Jacobs JF, de Vries IJ, Nierkens S and Adema GJ: Toll-like receptor signalling on Tregs: to suppress or not to suppress? Immunology 124: 445-452, 2008.
20. Caramalho I, Lopes-Carvalho T, Ostler D, et al: Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J Exp Med 197: 403-411, 2003.
21. Khattri R, Cox T, Yasayko SA and Ramsdell F: An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 4: 337-342, 2003.
22. Hori S, Nomura T and Sakaguchi S: Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061, 2003.
23. Sakaguchi S, Wing K, Onishi Y, Prieto-Martin P and Yamaguchi T: Regulatory T cells: how do they suppress immune responses? Int Immunol 21: 1105-1111, 2009.
24. Huber S, Schramm C, Lehr HA, et al: Cutting edge: TGF-beta signaling is required for the in vivo expansion and immunosuppressive capacity of regulatory CD4+CD25+ T cells. J Immunol 173: 6526-6531, 2004.
25. Molling JW, de Gruijl TD, Glim J, et al: CD4(+)CD25hi regulatory T-cell frequency correlates with persistence of human papillomavirus type 16 and T helper cell responses in patients with cervical intraepithelial neoplasia. Int J Cancer 121: 1749-1755, 2007.
26. Sun J, Walsh M, Villarino AV, et al: TLR ligands can activate dendritic cells to provide a MyD88-dependent negative signal for Th2 cell development. J Immunol 174: 742-751, 2005.
27. Kaisho T, Hoshino K, Iwabe T, Takeuchi O, Yasui T and Akira S: Endotoxin can induce MyD88-deficient dendritic cells to support T(h)2 cell differentiation. Int Immunol 14: 695-700, 2002.
28. Bais AG, Beckmann I, Lindemans J, et al: A shift to a peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CIN III lesions. J Clin Pathol 58: 1096-1100, 2005.